美國幹血點採集卡市場規模、佔有率和趨勢分析報告：按應用、按卡類型、按最終用途、按國家、細分市場預測，2024-2030 年

美國幹血點採集卡市場成長與趨勢：

根據 Grand View Research, Inc. 的最新報告，到 2030 年，美國乾血斑採集卡市場規模預計將達到 1.499 億美元，預測期內複合年成長率為 3.9%。

DBS 卡在新生兒篩檢中的應用不斷增加以及法醫學毒理學中 DBS 卡的使用不斷增加是市場成長的關鍵因素。根據美國衛生與公眾服務部 (HSS) 和衛生資源與服務管理局 (HRSA) 的說法，美國每個州都有一份新生兒篩檢的法律要求清單。

法醫學毒理學中擴大採用乾血斑採集卡，並且在新生兒篩檢中擴大使用，正在擴大這種有價值的診斷工具的範圍。這些卡片具有多種優點，包括易於採集檢體、儲存穩定性和成本效益。在法醫學毒理學中，DBS卡可以有效地檢測個體的各種物質，包括毒品、酒精和毒素。這些資訊對於確定死亡原因和識別潛在罪犯至關重要。

在新生兒篩檢中，DBS卡有助於及早發現遺傳和代謝疾病，從而及時介入並改善嬰兒健康。隨著研究的進展和分析技術的不斷進步，DBS卡在這些領域的使用預計將進一步擴大，有利於法醫學調查和新生兒保健，並對市場做出貢獻。

美國幹血點採集卡市場報告亮點

• 按應用分類，新生兒篩檢市場在 2023 年佔據最大收益佔有率，為 23.19%，預計在預測期內將以 3.3% 的複合年成長率大幅成長。這種成長是由於美國新生兒篩檢量大。
• 按卡片類型分類，Whatman 903 細分市場在 2023 年以最高收益佔有率32.33% 佔據市場主導地位，預計在整個預測期內將以最快的複合年成長率成長。
• 按最終用途分類，醫院和診所部門在 2023 年佔據最大收益佔有率。預計該細分市場在預測期內將呈現良好的複合年成長率。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第3章美國幹血點採集卡市場變數、趨勢與範圍

• 市場體系展望
  • 母市場展望
  • 相關/附隨市場展望
• 市場動態
  • 市場推動要素分析
  • 市場限制因素分析
• 美國幹血點採集卡市場分析工具
  • 產業分析-波特五力分析
  • PESTEL分析

第4章美國幹血點採集卡市場：應用估算及趨勢分析

• 2023年及2030年應用市場佔有率
• 細分儀表板
• 美國幹血點採集卡市場，依應用前景
• 2018-2030年市場規模、預測及趨勢分析
• 新生兒篩檢
• 傳染病檢查
• 治療藥物監測
• 法醫的
• 合約研究組織/研究
• 其他用途

第5章美國幹血點採集卡市場：卡型估算及趨勢分析

• 2023 年和 2030 年卡片類型市場佔有率
• 細分儀表板
• 美國幹血點採集卡市場，按卡類型展望
• 2018-2030年市場規模、預測及趨勢分析
• Whatman 903
• Ahlstrom 226
• FTA
• 其他

第6章美國幹血點採集卡市場：最終用途估計與趨勢分析

• 2023 年及 2030 年最終用途市場佔有率
• 細分儀表板
• 按最終用途分類的美國幹血點採集卡市場
• 2018-2030年市場規模、預測及趨勢分析
• 醫院/診所
• 診斷中心
• 其他

第7章美國幹血點採集卡市場：區域估算及趨勢分析

• 2023 年和 2030 年按地區分類的市場佔有率佔有率
• 細分儀表板
• 按區域前景分類的美國幹血點採集卡市場
• 2018-2030年市場規模、預測及趨勢分析
  • 西
  • 中西部
  • 東北
  • 西南
  • 東南

第8章 競爭格局

• 主要市場參與企業的最新趨勢和影響分析
• 公司/競爭對手分類
• 供應商情況
• 公司簡介
  • Whatman plc（Cytiva）
  • GE Healthcare
  • MilliporeSigma
  • QIAGEN LLC
  • PerkinElmer
  • Roche
  • Shimadzu Corporation
  • Ahlstrom-Munksjo
  • Eastern Business Forms, Inc.
  • CENTOGENE NV

U.S. Dried Blood Spot Collection Cards Market Growth & Trends:

The U.S. dried blood spot collection cards market size is anticipated to reach USD 149.9 million by 2030, growing at a CAGR of 3.9% during the forecast period, according to a new report by Grand View Research, Inc. The rising application in newborn screening and expanding utilization of DBS cards in forensic toxicology are significant factors contributing to the market growth. According to the U.S. Department of Health & Human Services (HSS) and Health Resources & Services Administration (HRSA), each state of the U.S. possesses its legal list of requirements for screening newborns.

The growing adoption of dried blood spot collection cards in forensic toxicology and their increasing use in newborn screening is expanding the scope of these valuable diagnostic tools. These cards offer several advantages, such as ease of sample collection, storage stability, and cost-effectiveness. In forensic toxicology, DBS cards enable efficient detection of various substances, including drugs, alcohol, and toxins, in individuals. This information is crucial for determining the cause of death and identifying potential criminals.

In newborn screening, DBS cards facilitate early detection of genetic disorders and metabolic diseases, allowing for timely interventions and improved health outcomes for infants. As research progresses and analytical techniques continue to advance, the utilization of DBS cards in these fields is expected to expand further, benefiting forensic investigations and newborn healthcare, and contributing to the market.

U.S. Dried Blood Spot Collection Cards Market Report Highlights:

• Based on application, the newborn screening segment held the largest revenue share of 23.19% in 2023 and is expected to grow at a significant CAGR of 3.3% during the forecast period. The growth is attributed to the larger number of newborn screenings in the U.S.
• Based in card type, the Whatman 903 segment dominated the market with the largest revenue share of 32.33% in 2023 and is expected to grow at the fastest CAGR throughout the forecast period
• Based on end-use, the hospitals & clinics segment accounted for the largest revenue share in 2023. The segment is expected to exhibit a lucrative CAGR over the forecast period

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Application
  • 1.2.2. Card Type
  • 1.2.3. End-use
  • 1.2.4. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Volume price analysis (Model 2)
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Application outlook
  • 2.2.2. Card Type outlook
  • 2.2.3. End-use outlook
• 2.3. Competitive Insights

Chapter 3. U.S. Dried Blood Spot Collection Cards Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
  • 3.2.2. Market restraint analysis
• 3.3. U.S. Dried Blood Spot Collection Cards Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape

Chapter 4. U.S. Dried Blood Spot Collection Cards Market: Application Estimates & Trend Analysis

• 4.1. Application Market Share, 2023 & 2030
• 4.2. Segment Dashboard
• 4.3. U.S. Dried Blood Spot Collection Cards Market by Application Outlook
• 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 4.4.1. Newborn Screening (NBS)
    • 4.4.1.1. Market estimates and forecasts 2018 - 2030 (USD Million)
  • 4.4.2. Infectious Diseases Testing
    • 4.4.2.1. Market estimates and forecasts 2018 - 2030 (USD Million)
  • 4.4.3. Therapeutic Drug Monitoring
    • 4.4.3.1. Market estimates and forecasts 2018 - 2030 (USD Million)
  • 4.4.4. Forensics
    • 4.4.4.1. Market estimates and forecasts 2018 - 2030 (USD Million)
  • 4.4.5. CRO/Research
    • 4.4.5.1. Market estimates and forecasts 2018 - 2030 (USD Million)
  • 4.4.6. Other Applications
    • 4.4.6.1. Market estimates and forecasts 2018 - 2030 (USD Million)

Chapter 5. U.S. Dried Blood Spot Collection Cards Market: Card Type Estimates & Trend Analysis

• 5.1. Card Type Market Share, 2023 & 2030
• 5.2. Segment Dashboard
• 5.3. U.S. Dried Blood Spot Collection Cards Market by Card Type Outlook
• 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 5.4.1. Whatman 903
    • 5.4.1.1. Market estimates and forecasts 2018 - 2030 (USD Million)
  • 5.4.2. Ahlstrom 226
    • 5.4.2.1. Market estimates and forecasts 2018 - 2030 (USD Million)
  • 5.4.3. FTA
    • 5.4.3.1. Market estimates and forecasts 2018 - 2030 (USD Million)
  • 5.4.4. Others
    • 5.4.4.1. Market estimates and forecasts 2018 - 2030 (USD Million)

Chapter 6. U.S. Dried Blood Spot Collection Cards Market: End-use Estimates & Trend Analysis

• 6.1. End-use Market Share, 2023 & 2030
• 6.2. Segment Dashboard
• 6.3. U.S. Dried Blood Spot Collection Cards Market by End-use Outlook
• 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 6.4.1. Hospitals & Clinics
    • 6.4.1.1. Market estimates and forecasts 2018 - 2030 (USD Million)
  • 6.4.2. Diagnostics Centers
    • 6.4.2.1. Market estimates and forecasts 2018 - 2030 (USD Million)
  • 6.4.3. Others
    • 6.4.3.1. Market estimates and forecasts 2018 - 2030 (USD Million)

Chapter 7. U.S. Dried Blood Spot Collection Cards Market: Regional Estimates & Trend Analysis

• 7.1. Regional Market Share, 2023 & 2030
• 7.2. Segment Dashboard
• 7.3. U.S. Dried Blood Spot Collection Cards Market by Regional Outlook
• 7.4. Market Size & Forecasts and Trend Analyses, 2018 - 2030 for the Following
  • 7.4.1. West
    • 7.4.1.1. Market estimates and forecasts 2018 - 2030 (USD Million)
  • 7.4.2. Midwest
    • 7.4.2.1. Market estimates and forecasts 2018 - 2030 (USD Million)
  • 7.4.3. Northeast
    • 7.4.3.1. Market estimates and forecasts 2018 - 2030 (USD Million)
  • 7.4.4. Southwest
    • 7.4.4.1. Market estimates and forecasts 2018 - 2030 (USD Million)
  • 7.4.5. Southeast
    • 7.4.5.1. Market estimates and forecasts 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Recent Developments & Impact Analysis, By Key Market Participants
• 8.2. Company/Competition Categorization
• 8.3. Vendor Landscape
  • 8.3.1. List of key distributors and channel partners
  • 8.3.2. Key customers
  • 8.3.3. Key company heat map analysis, 2023
• 8.4. Company Profiles
  • 8.4.1. Whatman plc (Cytiva)
    • 8.4.1.1. Company overview
    • 8.4.1.2. Financial performance
    • 8.4.1.3. Product benchmarking
    • 8.4.1.4. Strategic initiatives
  • 8.4.2. GE Healthcare
    • 8.4.2.1. Company overview
    • 8.4.2.2. Financial performance
    • 8.4.2.3. Product benchmarking
    • 8.4.2.4. Strategic initiatives
  • 8.4.3. MilliporeSigma
    • 8.4.3.1. Company overview
    • 8.4.3.2. Financial performance
    • 8.4.3.3. Product benchmarking
    • 8.4.3.4. Strategic initiatives
  • 8.4.4. QIAGEN LLC
    • 8.4.4.1. Company overview
    • 8.4.4.2. Financial performance
    • 8.4.4.3. Product benchmarking
    • 8.4.4.4. Strategic initiatives
  • 8.4.5. PerkinElmer
    • 8.4.5.1. Company overview
    • 8.4.5.2. Financial performance
    • 8.4.5.3. Product benchmarking
    • 8.4.5.4. Strategic initiatives
  • 8.4.6. Roche
    • 8.4.6.1. Company overview
    • 8.4.6.2. Financial performance
    • 8.4.6.3. Product benchmarking
    • 8.4.6.4. Strategic initiatives
  • 8.4.7. Shimadzu Corporation
    • 8.4.7.1. Company overview
    • 8.4.7.2. Financial performance
    • 8.4.7.3. Product benchmarking
    • 8.4.7.4. Strategic initiatives
  • 8.4.8. Ahlstrom-Munksjo
    • 8.4.8.1. Company overview
    • 8.4.8.2. Financial performance
    • 8.4.8.3. Product benchmarking
    • 8.4.8.4. Strategic initiatives
  • 8.4.9. Eastern Business Forms, Inc.
    • 8.4.9.1. Company overview
    • 8.4.9.2. Financial performance
    • 8.4.9.3. Product benchmarking
    • 8.4.9.4. Strategic initiatives
  • 8.4.10. CENTOGENE N.V.
    • 8.4.10.1. Company overview
    • 8.4.10.2. Financial performance
    • 8.4.10.3. Product benchmarking
    • 8.4.10.4. Strategic initiatives

List of Tables

• Table 1 List of abbreviations
• Table 2 U.S. Dried Blood Spot Collection Cards Market, by Application, 2018 - 2030 (USD Million)
• Table 3 U.S. Dried Blood Spot Collection Cards Market, by Card Type, 2018 - 2030 (USD Million)
• Table 4 U.S. Dried Blood Spot Collection Cards Market, by End-use, 2018 - 2030 (USD Million)
• Table 5 U.S. Dried Blood Spot Collection Cards Market, by Region, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Data triangulation techniques
• Fig. 3 Primary research pattern
• Fig. 4 Market research approaches
• Fig. 5 Value-chain-based sizing & forecasting
• Fig. 6 QFD modeling for market share assessment
• Fig. 7 Market formulation & validation
• Fig. 8 U.S. dried blood spot collection cards market: market outlook
• Fig. 9 U.S. dried blood spot collection cards competitive insights
• Fig. 10 Parent market outlook
• Fig. 11 Related/ancillary market outlook
• Fig. 12 Penetration and growth prospect mapping
• Fig. 13 U.S. dried blood spot collection cards market driver impact
• Fig. 14 U.S. dried blood spot collection cards market restraint impact
• Fig. 15 U.S. dried blood spot collection cards market: Application movement analysis
• Fig. 16 U.S. dried blood spot collection cards market: Application outlook and key takeaways
• Fig. 17 Newborn screening (NBS) market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 18 Infectious diseases testing estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 19 Therapeutic drug monitoring estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 20 Forensics market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 21 CRO/research estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 22 Other applications estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 23 U.S. dried blood spot collection cards market: Card type movement analysis
• Fig. 24 U.S. dried blood spot collection cards market: Card type outlook and key takeaways
• Fig. 25 Whatman 903 market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 26 Ahlstrom 226 market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 27 FTA market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 28 Others market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 29 U.S. dried blood spot collection cards market: End-use movement analysis
• Fig. 30 U.S. dried blood spot collection cards market: End-use outlook and key takeaways
• Fig. 31 Hospitals & clinics market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 32 Diagnostics centers market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 33 Others market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 34 U.S. dried blood spot collection cards market: Regional movement analysis
• Fig. 35 U.S. dried blood spot collection cards market: Regional outlook and key takeaways
• Fig. 36 West market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 37 Midwest market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 38 Northeast market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 39 Southwest market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 40 Southeast market estimates and forecasts, 2018 - 2030 (USD Million)